S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
A 100% Win Rate In 2022… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
The Bottom Is In For McCormick & Company
"Prepare for Five Years of Famine" (Ad)
3 More Downgrades To Put On Your Buy List 
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
A 100% Win Rate In 2022… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
The Bottom Is In For McCormick & Company
"Prepare for Five Years of Famine" (Ad)
3 More Downgrades To Put On Your Buy List 
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
A 100% Win Rate In 2022… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
The Bottom Is In For McCormick & Company
"Prepare for Five Years of Famine" (Ad)
3 More Downgrades To Put On Your Buy List 
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
A 100% Win Rate In 2022… (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
The Bottom Is In For McCormick & Company
"Prepare for Five Years of Famine" (Ad)
3 More Downgrades To Put On Your Buy List 
Buffett's company owns nearly 24% of Occidental Petroleum
NASDAQ:BRKR

Bruker - BRKR Price Target & Analyst Ratings

$76.22
-0.19 (-0.25%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$75.40
$76.28
50-Day Range
$67.46
$76.54
52-Week Range
$48.42
$76.85
Volume
481,036 shs
Average Volume
814,822 shs
Market Capitalization
$11.18 billion
P/E Ratio
38.30
Dividend Yield
0.26%
Price Target
$73.75

Bruker Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$73.75
-3.24% Downside
High Prediction$90.00
Average Prediction$73.75
Low Prediction$60.00
TypeCurrent
3/29/22 to 3/29/23
1 Month Ago
2/27/22 to 2/27/23
3 Months Ago
12/29/21 to 12/29/22
1 Year Ago
3/29/21 to 3/29/22
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$73.75$73.75$74.00$85.00
Predicted Upside-3.24% Downside15.01% Upside18.77% Upside13.15% Upside
Get Bruker Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

BRKR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BRKR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bruker Stock vs. The Competition

TypeBrukerComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.33
2.55
2.47
Consensus RatingHoldBuyHold
Predicted Upside-3.24% Downside228.86% Upside202.55% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/10/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$80.00 ➝ $90.00+24.46%
11/16/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$75.00+9.47%
10/21/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$70.00+25.04%
4/13/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell$73.00 ➝ $60.00-3.05%
2/14/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$84.00 ➝ $85.00+24.00%
11/2/2021Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$85.00 ➝ $90.00+10.81%
5/6/2021BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$73.00 ➝ $80.00+17.27%
2/17/2021Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ Hold$48.00 ➝ $65.00+2.39%
12/16/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$47.00 ➝ $57.00+4.47%
11/16/2020Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
7/20/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$43.00 ➝ $49.00+12.36%
5/13/2020Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stephen Unger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 3/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BRKR Price Target - Frequently Asked Questions

What is Bruker's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Bruker stock is Hold based on the current 1 sell rating and 2 buy ratings for BRKR. The average twelve-month price prediction for Bruker is $73.75 with a high price target of $90.00 and a low price target of $60.00. Learn more on BRKR's analyst rating history.

Do Wall Street analysts like Bruker more than its competitors?

Analysts like Bruker less than other Computer and Technology companies. The consensus rating for Bruker is Hold while the average consensus rating for computer and technology companies is Buy. Learn more on how BRKR compares to other companies.

Does Bruker's stock price have much upside?

According to analysts, Bruker's stock has a predicted upside of 15.01% based on their 12-month price targets.

What analysts cover Bruker?

Bruker has been rated by Citigroup in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:BRKR) was last updated on 3/29/2023 by MarketBeat.com Staff